Knowledge and Attitude towards Psychiatry among Nursing Staffs in Tertiary Health Care Hospital

Authors

  • Zilola Aramovna Djuraeva Assistant, Department of Endocrinology, Samarkand State Medical University, Samarkand, Republic of Uzbekistan
  • Gulnora Siddiqovna Togaeva Assistant, Department of Endocrinology, Samarkand State Medical University, Samarkand, Republic of Uzbekistan
  • Aziza Davranovna Davranova Assistant, Department of Endocrinology, Samarkand State Medical University, Samarkand, Republic of Uzbekistan

DOI:

https://doi.org/10.48112/acmr.v3i2.32

Keywords:

Glycemia, Metformin, Insulin, Basal Insulin

Abstract

Abstract Views: 99

Type 2 diabetes mellitus (DM) is one of the most common noncommunicable diseases on the globe. If at present the number of patients with diabetes in the world is 347 million people, then by 2025, according to scientists, this figure will reach at least 592 million, of which 90% will be in diabetes. Global trends in the incidence of type 2 diabetes are also observed in Uzbekistan. The total number of patients with diabetes in Uzbekistan amounted to 230610 (706.24 per 100 thousand people), of which type 1 diabetes – 18349 (56.2 per 100 thousand people), type 2 diabetes – 212261 (650,0 per 100 thousand people). As a percentage, patients with type 1 diabetes of the total number of patients with diabetes is 8.0%, patients with type 2 diabetes are 92.0%. Maintaining a constantly normal or near normal concentration of glucose in the blood slows down the onset and progression of late complications of type 2 diabetes. In the absence of achieving the target glycemic values against the background of the use of a rational combination of oral hypoglycemic drugs, it is shown that baseline action is added to insulin treatment to suppress liver gluconeogenesis and normalize fasting glucose. The combination of sulfonylurea derivatives (PSM) and basal insulin has been well studied and has proven. In addition, the combined use of metformin and insulin was widely used in the treatment of patients with type 2 diabetes mellitus (T2DM), however, at present there is no evidence base in favor of their joint appointment.

References

Statler A, Othus M, Erba HP, Chauncey TR, Radich JP, Coutre S, et al. Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies. Blood. 2018;131(25):2782– 2788. Available from: https://doi.org/10.1182/blood-2018-01- 826693.

Wilcox G. Insulin and Insulin Resistance. Clin Biochem Rev. 2005;26(2):19–39.

Bailey CJ. Biguanides and NIDDM. Diabetes Care. 1992;15(6):755–772. Available from: https://doi.org/10.2337/ diacare.15.6.755.

Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The Metabolic Syndrome. Endocr Rev. 2008;29(7):777–822. Available from: https://dx.doi.org/10.1210/er.2008-0024.

Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and mod- ulation by natural compounds. Ther Adv Cardiovasc Dis.2017;11(8):215–225. Available from: https://dx.doi.org/10. 1177/1753944717711379.

Brunetti L, Kalabalik J. Management of Type-2 Diabetes Mellitus in Adults. P T. 2012;37(12):687–696.

Balarajan Y, Selvaraj S, Subramanian SV. Health care and equity in India. Lancet . 2011;377(9764):505–515. Available from: https://dx.doi.org/10.1016/S0140-6736(10)61894-6.

Laakso M. Cardiovascular Disease in Type 2 Diabetes From Population to Man to Mechanisms. Diabetes Care. 2010;33(2):442–449. Available from: https://dx.doi.org/10. 2337/dc09-0749.

Stuart RM, Khan O, Abeysuriya R, Kryvchun T, Lysak V, Bredikhina A, et al. Diabetes care cascade in Ukraine: an analysis of breakpoints and opportunities for improved diabetes outcomes. BMC Health Serv Res. 2020;20(1):409. Available from: https://doi.org/10.1186/s12913-020-05261-y.

Winiarska A, Filipska I, Knysak M, Stompór T. Dietary Phos- phorus as a Marker of Mineral Metabolism and Progression of Diabetic Kidney Disease. Nutrients. 2021;13(3):789. Available from: https://dx.doi.org/10.3390/nu13030789.

Agrawal P, Philip R, Saran S, Gutch M, Razi MS, Agroiya P, et al. Congenital hypothyroidism. Indian J Endocrinol Metab. 2015;19(2):221–227. Available from: https://dx.doi.org/10.4103/2230-8210.131748.

Cheng AYY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ . 2005;172(2):213–226. Available from: https://dx.doi.org/10.1503/cmaj.1031414.

Colwell JA. Multifactorial aspects of the treatment of the type II diabetic patient. Metabolism. 1997;46(12):1–4. Available from: https://doi.org/10.1016/s0026-0495(97)90308-5.

Suratovich OF, Siddikovna TG, Davranovna DA. Structural Features of Cells of the Islets of Langerhans in Offspring with Alloxonic Diabetes (Review Article). Annals of RSCB. 2021;25(1):158–162.

Suratovich OF, Siddikovna TG, Davranovna DA. Structural Features of Cells of the Islets of Langerhans in Offspring with Alloxonic Diabetes (Review Article). Ann Romanian Soc Cell Biol. 2021;25(1):158–162.

Djuraeva ZA, Rasulova SK, Mustafakulov IB. Biogeochemical Factors Affecting The Health Conditions Of The Mother And Child. Int J Res. 2020;7(4):578–584.

Spann SJ, Nutting PA, Galliher JM, Peterson KA, Pavlik VN, Dickinson LM, et al. Management of type 2 diabetes in the primary care setting: a practice-based research network study. Ann Fam Med. 2006;4(1):23–31. Available from: https://doi.org/10.1370/afm.420

Advances in Clinical Medical Research

Downloads

Published

2022-06-30

How to Cite

Djuraeva, Z. A., Togaeva, G. S., & Davranova, A. D. (2022). Knowledge and Attitude towards Psychiatry among Nursing Staffs in Tertiary Health Care Hospital. Advances in Clinical Medical Research, 3(2), 04–06. https://doi.org/10.48112/acmr.v3i2.32

Issue

Vol. 3 No. 2 (2022): April-June 2022

Section

Articles

License

Copyright (c) 2022 Advances in Clinical Medical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Most read articles by the same author(s)